Last 47 quarters of trend data · Healthcare · Medical - Instruments & Supplies
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -17.63 | — | — | — | — | — | — | — | — | — | — | — | 1.75 | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 2.00 | 1.38 | 1.52 | 1.62 | 1.39 | 1.30 | 1.32 | 0.97 | 1.12 | 0.90 | 0.73 | 0.83 | 1.02 | 1.03 | 1.52 | 1.50 | 2.67 | 2.21 | 3.11 | 3.21 | 3.56 |
| — | +5.5% | +15.1% | +66.0% | +24.2% | +45.1% | +79.4% | +17.2% | +10.2% | -12.6% | -51.5% | -44.5% | -61.8% | -53.4% | -51.3% | -53.4% | -25.1% | -23.8% | +10.1% | +71.5% | +179.8% | |
| P/B Ratio | 3.77 | 2.79 | 2.74 | 2.91 | 2.36 | 2.28 | 2.04 | 1.52 | 1.54 | 1.24 | 1.01 | 0.65 | 0.75 | 0.99 | 1.23 | 1.25 | 2.10 | 1.81 | 2.14 | 2.33 | 2.51 |
| — | +22.1% | +34.4% | +91.8% | +53.1% | +84.1% | +102.2% | +132.0% | +105.6% | +25.3% | -17.9% | -47.8% | -64.3% | -45.3% | -42.5% | -46.1% | -16.4% | -10.7% | +21.2% | +93.9% | +220.2% | |
| P/FCF | 1261.94 | 6.99 | — | 30.28 | — | 5.80 | — | 42.30 | — | 14.38 | — | 13.93 | — | 6.52 | 745.61 | 18.92 | — | 25.55 | — | 310.37 | — |
| — | +20.7% | — | -28.4% | — | -59.7% | — | +203.6% | — | +120.4% | — | -26.3% | — | -74.5% | — | -93.9% | — | +32.9% | — | +2197.8% | — | |
| EV / EBITDA | — | — | — | 36.34 | — | 2068.28 | — | — | — | — | — | — | 1.61 | — | — | — | — | 152.30 | 109.06 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +47.9% | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.6% | 57.1% | 52.9% | 53.1% | 55.3% | 52.7% | 54.0% | 54.8% | 54.4% | 54.3% | 47.7% | 50.9% | 50.9% | 50.9% | 50.2% | 52.8% | 51.9% | 53.4% | 52.2% | 51.8% | 52.1% |
| — | +8.3% | -2.0% | -3.2% | +1.6% | -2.9% | +13.1% | +7.6% | +6.9% | +6.6% | -5.0% | -3.5% | -1.9% | -4.7% | -3.8% | +1.9% | -0.5% | -3.0% | -3.6% | -6.2% | +2.4% | |
| Operating Margin | -12.5% | -23.5% | -8.2% | -3.1% | -14.1% | -7.2% | -13.9% | -15.2% | -19.4% | -20.4% | -265.9% | -16.6% | 44.5% | -22.9% | -11.1% | -9.5% | -16.3% | -7.4% | -7.2% | -11.1% | -10.5% |
| — | -225.4% | +40.8% | +79.4% | +27.5% | +64.5% | +94.8% | +8.2% | -143.6% | +11.0% | -2303.7% | -74.7% | +372.9% | -211.2% | -54.5% | +14.3% | -55.0% | +73.8% | -36.3% | -66.8% | -44.3% | |
| Net Margin | -11.5% | -13.2% | -10.3% | -8.0% | -14.4% | -7.5% | -6.1% | -14.7% | -19.0% | -18.9% | -249.7% | -36.7% | 58.3% | -23.6% | -11.8% | -9.9% | -15.9% | -7.2% | -6.7% | -10.7% | -9.1% |
| — | -74.5% | -68.4% | +45.8% | +24.1% | +60.2% | +97.5% | +59.9% | -132.5% | +19.6% | -2024.9% | -269.8% | +465.7% | -227.3% | -75.3% | +6.9% | -76.1% | +71.6% | -34.6% | -81.9% | -49.0% |
| Metric | TTM | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -20.8% | -6.6% | -4.6% | -3.6% | -6.0% | -3.3% | -2.4% | -5.6% | -6.4% | -6.3% | -60.6% | -7.0% | 11.4% | -5.5% | -2.4% | -2.1% | -3.1% | -1.5% | -1.2% | -1.9% | -1.6% |
| — | -102.0% | -95.5% | +36.2% | +5.3% | +48.3% | +96.1% | +20.1% | -155.9% | -14.6% | -2472.2% | -239.4% | +467.0% | -277.1% | -104.7% | -7.3% | -94.7% | +66.3% | -47.6% | -104.9% | -70.0% | |
| ROA | -13.4% | -4.3% | -3.0% | -2.4% | -4.0% | -2.1% | -1.5% | -3.7% | -4.2% | -4.2% | -45.5% | -5.8% | 8.9% | -4.0% | -1.7% | -1.5% | -2.3% | -1.1% | -0.9% | -1.5% | -1.2% |
| — | -102.0% | -99.6% | +35.4% | +4.6% | +48.9% | +96.6% | +37.2% | -146.8% | -4.9% | -2543.3% | -284.4% | +481.7% | -249.1% | -90.6% | -1.1% | -87.7% | +66.4% | -49.3% | -106.7% | -72.4% | |
| ROIC | -23.6% | -11.6% | -3.3% | -1.3% | -5.6% | -3.1% | -5.3% | -5.9% | -7.0% | -7.8% | -61.3% | -2.7% | 6.8% | -3.8% | -1.6% | -1.4% | -2.3% | -1.1% | -0.9% | -1.5% | -1.5% |
| — | -277.5% | +37.7% | +78.5% | +20.4% | +60.6% | +91.4% | -114.2% | -203.0% | -105.6% | -3817.2% | -94.9% | +395.9% | -239.5% | -68.4% | +8.5% | -58.2% | +71.0% | -43.8% | -86.8% | -68.1% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | 0.07 | 0.07 | 0.05 | 0.06 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.17 | 0.15 | 0.12 | 0.12 | 0.08 | 0.06 | 0.06 | 0.06 |
| — | — | +144.3% | +151.8% | +119.6% | +141.1% | +48.3% | +152.5% | +121.1% | -86.5% | -87.9% | -91.4% | -90.8% | +114.5% | +158.0% | +111.1% | +109.7% | +74.9% | -11.8% | -34.3% | -34.8% | |
| Debt / EBITDA | — | — | — | 3.54 | — | 225.47 | — | — | — | — | — | — | 0.11 | — | — | — | — | 26.60 | 11.84 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +4.3% | — | — | |
| Current Ratio | 2.19 | 2.19 | 2.35 | 2.24 | 2.29 | 2.21 | 2.21 | 1.98 | 2.25 | 2.12 | 2.29 | 2.38 | 3.05 | 1.95 | 2.19 | 2.16 | 2.28 | 1.93 | 2.59 | 2.43 | 2.52 |
| — | -1.0% | +6.6% | +13.3% | +2.0% | +4.2% | -3.6% | -16.7% | -26.3% | +8.7% | +4.6% | +10.1% | +34.0% | +1.2% | -15.3% | -11.0% | -9.5% | -21.2% | -10.8% | -25.7% | -29.4% | |
| Quick Ratio | 1.49 | 1.49 | 1.47 | 1.33 | 1.38 | 1.40 | 1.40 | 1.24 | 1.41 | 1.46 | 1.62 | 1.55 | 2.01 | 1.29 | 1.28 | 1.30 | 1.41 | 1.24 | 1.61 | 1.54 | 1.57 |
| — | +6.4% | +4.8% | +7.7% | -1.7% | -4.1% | -13.4% | -20.5% | -30.0% | +12.7% | +26.4% | +19.5% | +42.4% | +4.3% | -20.7% | -15.7% | -10.3% | -22.8% | -16.1% | -29.4% | -29.9% | |
| Interest Coverage | -120.40 | -104.10 | -90.73 | -61.30 | -2708.50 | — | — | — | — | — | — | — | — | -23.27 | -7.24 | -4.99 | -35.37 | -35.33 | -32.28 | -49.94 | -54.18 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ANGO stock.
AngioDynamics, Inc.'s current P/E is -17.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
AngioDynamics, Inc.'s current operating margin is -12.5%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking AngioDynamics, Inc.'s business trajectory between earnings reports.